Innate Pharma SA (IPH) Stock Price & News

Why is IPH up 5.03%?

Dive Deeper

IPH:EPA

Innate Pharma SA

€1.25

+5.03%

(+0.060) 1D

Nov 4, 5:35:01 PM GMT+1 · EUR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for IPH...

Open

€1.18

High

€1.28

Low

€1.17

Mkt. cap

130.95M

Avg. vol.

222.31K

Volume

305.64K

52-wk high

€2.33

52-wk low

€1.03

EPS

-€0.51

Shares outstanding

111.72M

No. of employees

120

Open

€1.18

High

€1.28

Low

€1.17

Mkt. cap

130.95M

Avg. vol.

222.31K

Volume

305.64K

52-wk high

€2.33

52-wk low

€1.03

EPS

-€0.51

Shares outstanding

111.72M

No. of employees

120

Related stocks

Valerio Therapeutics SA

News stories

From web sources and news partners

Yahoo Finance

52 minutes ago

Dow, S&P 500, Nasdaq Futures Mixed After A Democratic Sweep In Midterms: NVDA, MU, SNDK, NBIS, IREN In Focus

WXOW

27 minutes ago

Dow has best post-midterm elections day in 44 years as Democrats take control of Congress

www.marketscreener.com

27 minutes ago

Backblaze Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

PBS

7 hours ago

U.S. stocks surge, and the Dow soars 1,500 points as Brent oil's price drops below $95 per barrel

About Innate Pharma SA

CEO-

Employees120

Founded1999

Headquarters-

SectorBiotechnology

Industry-

Websiteinnate-pharma.com

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2.07M	2.07M	2.83M	2.83M
Cost of goods sold	11.55M	11.55M	8.44M	8.44M
Cost of revenue	11.55M	11.55M	8.44M	8.44M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.81M	4.81M	3.90M	3.90M
Operating expense	4.81M	4.81M	3.90M	3.90M
Total operating expenses	16.36M	16.36M	12.34M	12.34M
Operating income	-14.29M	-14.29M	-9.51M	-9.51M
Other non operating income	144.00K	144.00K	44.00K	44.00K
EBT including unusual items	-13.92M	-13.92M	-9.81M	-9.81M
EBT excluding unusual items	-13.92M	-13.92M	-9.81M	-9.81M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-13.92M	-13.92M	-9.81M	-9.81M
Net profit margin	-671.48%	-671.48%	-346.51%	-346.51%
Earnings per share	-	-	-	-
Interest and investment income	262.50K	262.50K	139.50K	139.50K
Interest expense	-105.50K	-105.50K	-85.00K	-85.00K
Net interest expenses	157.00K	157.00K	54.50K	54.50K
Depreciation and amortization charges	-	-	-	-
EBITDA	-14.12M	-14.12M	-9.36M	-9.36M
Gain or loss from assets sale	1.50K	1.50K	96.50K	96.50K

Ask anything